Follow Us on Google
Shareholders of Fidson Healthcare Plc have approved a N3.6 billion dividend for the 2025 financial year following the company’s record-breaking performance, which saw it become the first pharmaceutical manufacturer in Nigeria to surpass N100 billion in annual revenue.
The shareholders gave the approval at the company’s 27th Annual General Meeting (AGM), endorsing a dividend of N1.50 per 50 kobo ordinary share alongside other statutory resolutions, including the election and re-election of directors and the appointment of members of the Statutory Audit Committee.
Fidson reported revenue of N119.06 billion for the 2025 financial year, describing the result as a major milestone in its growth. The performance comes a year after the transition in the company’s board and management leadership.
Chairman and Founder, FIDSON, Dr. Fidelis Ayebae, said the record earnings reflected the company’s long-term growth strategy, investments in manufacturing and the confidence of shareholders.
He also credited recent government policies aimed at supporting local pharmaceutical manufacturing, saying they had helped improve the operating environment and strengthened the capacity of indigenous manufacturers to meet rising demand for affordable medicines.
Ayebae disclosed that the company’s ongoing expansion projects are at an advanced stage and, when completed, are expected to significantly increase its manufacturing capacity. He said the projects would support Fidson’s ambition of becoming the largest pharmaceutical manufacturing company in Sub-Saharan Africa.
Also, Managing Director and Chief Executive Officer, Mr. Biola Adebayo, said the company would sustain its growth by expanding production, introducing more products, deepening market penetration and exploring opportunities across Africa.
He added that the company would continue to invest in innovation and manufacturing efficiency to strengthen its competitiveness and create long-term value for shareholders.
Shareholders commended the board and management for maintaining growth despite prevailing economic challenges and expressed support for the company’s expansion plans.
The AGM also approved resolutions on auditors’ remuneration and corporate governance matters, while the company reaffirmed its commitment to electronic shareholder services, including e-dividend payments, digital annual reports and virtual participation at annual meetings.
